✦ LIBER ✦

PND1 12-Month Clinical Evolution of Moderate Alzheimer'S Disease Patients in Spain: The Evocost Study

✍ Scribed by Frank-Garcia, A.; Salva, A.; Lereun, C.; Gimeno, V.; Milea, D.; Bineau, S.

Book ID: 122316258
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 57 KB
Volume: 15
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2012.08.1925

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PND20 12-Month Cost of Illness Study of

PND20 12-Month Cost of Illness Study of Moderate Alzheimer'S Disease Patients in Spain: The Evocost Study

✍ Salva, A.; Frank-Garcia, A.; Lereun, C.; Gimeno, V.; Milea, D.; Bineau, S. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

0728 Epidemiological evolutive study of

0728 Epidemiological evolutive study of moderate to severe Alzheimer's disease (AD) in Spain (5E study). 12 months follow-up evaluation

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 128 KB

O1-05-06 Clinical data on Alzhemed™ afte

O1-05-06 Clinical data on Alzhemed™ after 12 months of treatment in patients with mild to moderate Alzheimer's disease

✍ Paul A. Aisen; Mariam Mehran; Ruth Poole; Isabelle Lavoie; Francine Gervais; Ric 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 157 KB

PND10 COST-EFFECTIVENESS STUDY IN PATIEN

PND10 COST-EFFECTIVENESS STUDY IN PATIENTS WITH MILD TO MODERATELY SEVERE ALZHEIMER'S DISEASE: PROJECTED BENEFITS OF DONEPEZIL IN THE UNITED KINGDOM

✍ D Getsios; S Blume; KJ Ishak; G MacLaine 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

A multinational, randomised, 12-week stu

A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease

✍ Roy W. Jones; Hilkka Soininen; Klaus Hager; Dag Aarsland; Peter Passmore; Anita 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB 👁 2 views

## Abstract ## Objectives To compare directly, in the same patient cohort, the ease of use and tolerability of donepezil and galantamine in the treatment of Alzheimer's disease (AD), and investigate the effects of both treatments on cognition and activities of daily living (ADL). ## Methods Pati

Cognitive and affective changes in mild-

Cognitive and affective changes in mild-to-moderate Alzheimer's disease patients undergoing switch of cholinesterase inhibitors enrolled in the EVOLUTION study: The effect of different inhibitor/formulation

✍ Spalletta, Gianfranco; Caltagirone, Carlo; Padovani, Alessandro; Sorbi, Sandro; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 49 KB